|
CD4CAR Clinical Trials
3 actively recruiting trials across 1 location
Miami, Florida3 trials
CD4CAR for CD4+ Leukemia and Lymphoma
University of Miami Sylvester Comprehensive Cancer Center
Phase 1
Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant
University of Miami Sylvester Comprehensive Cancer Center
Phase 1
Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.
University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida 33136
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.